Journal Article10.1016/S1569-9056(14)60029-4
27 Protocol based versus non-protocol based discontinuation in the Prostate cancer Research International: Active Surveillance (PRIAS) study
L.P. Bokhorst,J.W. Salman,Lionne D.F. Venderbos,Antti Rannikko,Riccardo Valdagni,Tom Pickles,Yoshiyuki Kakehi,C.H. Bangma,Monique J. Roobol +8 more
1
About: This article is published in European Urology Supplements. The article was published on 01 Apr 2014. The article focuses on the topics: Discontinuation & Prostate cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The ProtecT trial: what can we expect?
TL;DR: The data for the recruitment phase of the Prostate testing for cancer and Treatment (ProtecT) trial is presented, and the primary analysis consists of calculating the 10-year prostate cancer mortality risk and its confi dence interval per treatment modality using adjusted Cox proportional hazard regression.
6